B+
Bull case
25%
Probability
Target price
$100.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
CTVA
CortevaCNYSE / Materials
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$86.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$65.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-04
Recent news sentiment (30D)
+24.3
Positive
Company
-
Unavailable
Macro
+24.3
Positive
Pulse
-
Unavailable
Weekly research (10D)
-24.0
Negative
Sentiment proxy
+62.8
Score
AI commentary
News tone is positive on the earnings beat, raised outlook and separation progress, but mixed because sales missed consensus and CTVA traded at $75.14 on August 4 versus a $76.04 prior close, a 1.18% decline. Available post-print analyst updates were target increases with maintained ratings from UBS, BMO Capital and JPMorgan, but no verified rating changes or estimate revisions beyond those target updates were identified. The reaction is therefore constructive on fundamentals but not yet a confirmed bullish rerating. [https://stockanalysis.com/stocks/ctva/](https://stockanalysis.com/stocks/ctva/) [https://www.investing.com/equities/corteva-consensus-estimates](https://www.investing.com/equities/corteva-consensus-estimates)
RankAlpha Sentiment Codex - 2026-08-04
Open post-earnings memoEvidence flagged
later post-earnings follow-up lacks concrete company-source and analyst/market reaction evidence
Impact
tentative
Confidence
-
AI events
2026-08-15eventQ2 beat and FY2026 outlook increaseMedium impact
Corteva reported Q2 operating EPS of $2.30 and operating EBITDA of $2.26 billion; the company raised FY2026 operating EBITDA guidance to $4.1-$4.3 billion and operating EPS guidance to $3.60-$3.80. Revenue declined 1% year over year and missed consensus, making the signal positive but mixed. [#SEC-8K-2026-07-30] [#PR-EARNINGS-2026-07-31]
2026-08-15catalystPost-earnings digestion and crop-protection pressureMedium impact
Near-term upside may be constrained by the Q2 sales miss, lower crop-protection pricing, volume timing shifts and uncertainty around second-half execution and separation costs. StockAnalysis showed CTVA at $75.14 versus the $76.04 prior close on August 4, down 1.18%, but did not establish causal attribution. [https://stockanalysis.com/stocks/ctva/](https://stockanalysis.com/stocks/ctva/)
2026-10-01eventPlanned October 1 separationMedium impact
Management said Corteva remains on track to complete the planned separation, targeting an October 1 Vylor spin-off date. Execution, dis-synergies and investor treatment of the two businesses remain key variables. [#SEC-8K-2026-07-30] [#EARNINGS-TRANSCRIPT-2026Q2]
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-04 • Updated nightlySource: Internal modelMethodology